The EACR Advisory Council provides advice and guidance to the EACR Board and plays an important role in ensuring the EACR is successful in its mission to support European cancer researchers.
Mariano Barbacid, AXA-CNIO Professor of Molecular Oncology, Spanish National Cancer Research Center (CNIO)
Johanna Bendell, Global Head Oncology, Roche Pharma Research and Early Development
Anton Berns, Chair
Margaret Foti, Chief Executive Officer, AACR
Susan Galbraith, Executive Vice President, Oncology Research & Development, AstraZeneca
Carl-Henrik Heldin, Uppsala University, Sweden
Olli Kallioniemi, SciLifeLab, Sweden
Sir Harpal Kumar, President, GRAIL Europe
Daniel Louvard, former Director of the Curie Institute
Richard Marais, Co-Director and Chief Scientific Officer, Oncodrug Ltd
Elaine Mardis, Co-Executive Director, The Institute for Genomic Medicine at Nationwide Children’s Hospital and Professor of Pediatrics, The Ohio State University College of Medicine
Alberto Mantovani, Scientific Director, Istituto Clinico Humanitas, Emeritus Professor, Humanitas University, Milan
Moshe Oren, Professor emeritus, Weizmann Institute of Science
Marta Puyol, Scientific Director, Spanish Association against Cancer Scientific Foundation (FC AECC)
Charlie Swanton, CRUK Chief Clinician
Fiona Watt, Director of EMBO
Otmar Wiestler, President of the Helmholtz Association